Investment in Renewables
Hamilton Locke advises Novacyt SA on its acquisition of Southern Cross Diagnostics Pty Ltd
Hamilton Locke advised listed France-based molecular diagnostic group Novacyt, through its wholly owned UK subsidiary Novacyt UK Holdings Limited, on its announced acquisition of Southern Cross Diagnostics Pty Ltd, a leading Sydney-based distributor specialising in diagnostic and life sciences products. Hamilton Locke worked alongside the corporate teams at Addleshaw Goddard LLP and Frieh Brault & […]
